KNOWLEDGE BANK

Interviews

mRNA Platforms as Diagnostics and Therapeutics for Human Infertility Treatments

Associate Professor, Department of Biology, Khalifa University
Junaid Kashir is an Associate Professor in the Department of Biology at Khalifa University and has previously chaired multiple researchadministrative committees He has been heavily involved in multiple programs for training graduate clinical embryology students Dr Kashirs research aims to develop therapeuticdiagnostic interventions to treat infertility and understand embryology

Articles

Meaningful Advances in Virtual Cells

It seems that everyone in biotech is working on virtual cells A multiscale multimodal model that can simulate the behavior of human molecules cells and tissues across diverse states would be a gamechanger in AI drug discovery allowing researchers to predict the success of millions of possible treatments on cells before more expensive laboratory testing vastly scaling up the speed and efficiency o...

Research Insights

In Silico Product Design Of Pharmaceuticals

Abstract The increasing demand for personalized medicine necessitates the production of easily customizable dosage forms As the number of possible dosage forms may scale toward infinity their uniqueness requires a versatile production platform and numerical simulation in order to be manufactured efficiently A mathematical description of these systems is the only

Case Studies

Ambient Stable Biologics - Stable Aqueous Erythropoietin

Challenge Erythropoietin EPO is known to aggregate under heat stress which prevents storage of liquid compositions at ambient temperature The key challenge of this study was to demonstrate that the application of the ArestatT tools can reduce significantly aggregation of EPO at an elevated temperature compared with a marketed liquid formulation

Techno Trends

Trinity Researchers Discovered a New Breakthrough for Asthma Patients

A new breakthrough has been discovered by the researchers from Trinity College Dublin for people living with asthmathat may eventually lead to improved therapeutic options An important role in defending against bacteria is played by Caspase However it has never been implicated in this disease before

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Evolution of eCTD from version 1 to 4

Gouspasha Mohammed

Gouspasha is a seasoned professional with 12 years of experience in the pharmaceutical industry, specializing in eCTD (Electronic Common Technical Document) publishing and submission. With a strong focus on regulatory compliance and efficient document management, Gouspasha ensures seamless and timely submissions. Dedicated to maintaining the highest standards of quality and accuracy, Gouspasha remains committed to staying current with evo0lving industry trends and regulatory requirements.

2

Nanoemulsion - A Promising Nanocarrier for Dermal Drug Delivery in Psoriasis

Sindhoor S M

Sindhoor S M is currently working as an Assistant Professor in the Department of Pharmaceutics at Sri Adichunchanagiri College of Pharmacy, Mandya, Karnataka. His areas of specialisation include nanotechnology-based drug delivery system, lipid-based formulations, Topical delivery and gastroretentive in situ gel systems. He has published eight papers based on nanotechnology and lipid-based drug delivery system in peer reviewed indexed journals. Presently he is involved in the development of lipid-based delivery systems.

 

Marina Koland

Marina Koland, is Professor and Head of the Department of Pharmaceutics at the NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore. Her area of specialisation in research is mucoadhesive and nanoparticulate drug delivery. She has published 50 research papers in peer reviewed journals, presented papers at 10 National and 3 International Conferences and worked on several Nitte University funded projects. She is currently working on solid lipid nanoparticles and micelles as drug carriers for targeting.

 

3

Approach for Producing Pharmaceuticals in Layer By Layer Fashion: Additive Manufacturing

Lakshmi usha Ayalasomayajula

Lakshmi usha Ayalasomayajula is an Assistant Professor in the Department of Pharmaceutical Technology at M.R. College of Pharmacy, India with 9 years of teaching and research experience. She has published 30 papers in international and national journals and has presented 20 papers in various conferences as author and co-author.

 

Earle Radha Rani

Earle Radha Rani is working as assistant professor in department of pharmaceutical technology, Maharajah’s College of Pharmacy, Andhra Pradesh, India. She has 7 years of teaching experience and has published over 30 research and review articles in several reputed national and international journals. Her areas of interest include novel drug delivery systems.

 

AVS Ksheera Bhavani

AVS Ksheera Bhavani is working as assistant professor in department of Pharmaceutical Biotechnology, Maharajah’s College of Pharmacy, Andhra Pradesh, India. She has about 10 years of teaching experience and has published over 10 research and review articles in several reputed national and international journals. Her areas of interest include novel drug delivery systems.

 

Kishore Pathivada

kishore pathivada ,an under graduate from Maharajah's college of pharmacy, Vizianagaram, during the year, 2017-21. I Qualified GPAT-2021 with AIR 705 and I also got qualified in NIPER JEE-2021 with AIR 62.Currently Iam pursuing my master's degree in Dept. of pharmaceutical Analysis at NIPER Mohali, Punjab which is one of the top most reputed colleges in INDIA in the field of Pharmaceutical Sciences and Research.

 

4

The Role of Bioinformatics in Accelerating Translational Research

Vasundhara Dauneria

Vasundhara Dauneria is a biotechnology professional with over six years of experience spanning genomics, next-generation sequencing, and bioinformatics. She has worked across wet-lab and computational research environments, with hands-on expertise in NGS workflows, assay development, and multi-omics data analysis. Her work focuses on applying data-driven approaches to support translational research and precision medicine initiatives.

5

Reshaping the Clinical Trial Model

Anna Hayes

Anna Hayes is a senior data management leader (At Veramed) with nearly 20 years of experience in clinical research. She specializes in biometrics strategy, innovation, and operational excellence, driving smarter oversight and data-driven trial execution. Anna is passionate about integrating people, processes, and technology to future-proof clinical trials and elevate data quality.

press releasesRead more...

ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer

AstraZenecas ETCAMAH camizestrant in combination with a cyclindependent kinase CDK inhibitor abemaciclib palbociclib or ribociclib has been approved in the US for the treatment of adult patients

Global Experts to Gather in Osaka for PDA Aseptic Manufacturing and Regulatory Science Symposium 2026

As pharmaceutical manufacturers worldwide continue to navigate the implementation of PICS GMP Annex a landmark international symposium in Japan will bring together regulators industry leaders

Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform

Integrated DNA Technologies IDT a Danaher company and a global leader in genomics and Ansa Biotechnologies Inc a trusted partner for DNA synthesis today announced an expansion of their partnership

Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience

Biocytogen Pharmaceuticals Beijing Co Ltd Biocytogen SSE HKEX today announced that it has entered into a nonexclusive licensing agreement with Qilu Pharmaceutical Co Ltd

Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates

Heidelberg Pharma AG FSE HPHA a clinicalstage biotech company developing innovative Antibody Drug Conjugates ADCs today announced that its whollyowned subsidiary Heidelberg Pharma Research

LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China

Eisai Co Ltd and Biogen Inc Nasdaq BIIB announced today that the National Medical Products Administration NMPA of China has approved the subcutaneous formulation subcutaneous autoinjector SCAI

EventsRead more...

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

LATEST NEWSRead more...

ZANVASTRO approved by FDA as first disease-modifying treatment for Alexander disease

Ionis Pharmaceuticals has received approval from the US Food and Drug Administration FDA for ZANVASTRO zilganersen to treat Alexander disease AxD in paediatric and adult patients

Global Experts to Gather in Osaka for PDA Aseptic Manufacturing and Regulatory Science Symposium 2026

As pharmaceutical manufacturers worldwide continue to navigate the implementation of PICS GMP Annex a landmark international symposium in Japan will bring together regulators industry leaders

HUTCHMED Enters into Agreement with GSK for Novel KRAS-EGFR Cancer Therapy

HUTCHMED has entered into an exclusive development and licensing agreement with GSK for HMPLA an investigational antibodytargeted therapy conjugate ATTC designed to target KRAS and EGFR in solid tumours

Everest Medicines Receives Approval for CARDAMYST to Treat Acute PSVT

Everest Medicines has received approval from Chinas National Medical Products Administration NMPA for CARDAMYST etripamil nasal spray for the conversion of acute symptomatic episodes

HUTCHMED Announces Approval of ATLED® (Fanregratinib) for FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma

HUTCHMED has received conditional approval from Chinas National Medical Products Administration NMPA for ATLED fanregratinib to treat adults with advanced metastatic or unresectable intrahepatic cholangiocarcinoma ICC with FGFR fusion or rearrangement who have previously received systemic therapy

Osivax Enters into Collaboration with GC Biopharma to Develop Next-Generation Influenza Vaccine

Osivax and GC Biopharma have entered into a strategic collaboration to develop and commercialise a nextgeneration seasonal influenza vaccine designed to provide broader and more durable protection against a range of influenza strains